These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35428497)

  • 21. A review of the safety and efficacy of current COVID-19 vaccines.
    Huang Z; Su Y; Zhang T; Xia N
    Front Med; 2022 Feb; 16(1):39-55. PubMed ID: 35122210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 vaccination during pregnancy: coverage and safety.
    Blakeway H; Prasad S; Kalafat E; Heath PT; Ladhani SN; Le Doare K; Magee LA; O'Brien P; Rezvani A; von Dadelszen P; Khalil A
    Am J Obstet Gynecol; 2022 Feb; 226(2):236.e1-236.e14. PubMed ID: 34389291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion.
    Vazquez-Benitez G; Haapala JL; Lipkind HS; DeSilva MB; Zhu J; Daley MF; Getahun D; Klein NP; Vesco KK; Irving SA; Nelson JC; Williams JTB; Hambidge SJ; Donahue J; Fuller CC; Weintraub ES; Olson C; Kharbanda EO
    Am J Epidemiol; 2023 Aug; 192(8):1386-1395. PubMed ID: 36928091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.
    Lipkind HS; Vazquez-Benitez G; DeSilva M; Vesco KK; Ackerman-Banks C; Zhu J; Boyce TG; Daley MF; Fuller CC; Getahun D; Irving SA; Jackson LA; Williams JTB; Zerbo O; McNeil MM; Olson CK; Weintraub E; Kharbanda EO
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(1):26-30. PubMed ID: 34990445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination coverage levels among children enrolled in the Vaccine Safety Datalink.
    McCarthy NL; Irving S; Donahue JG; Weintraub E; Gee J; Belongia E; Baggs J
    Vaccine; 2013 Dec; 31(49):5822-6. PubMed ID: 24135576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a COVID-19 vaccine effectiveness and safety assessment system in Japan: The VENUS study.
    Fukuda H; Maeda M; Murata F
    Vaccine; 2023 May; 41(23):3556-3563. PubMed ID: 37037707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety Monitoring after the BNT162b2 COVID-19 Vaccine among Adults Aged 75 Years or Older.
    Choi YY; Kim MK; Kwon HC; Kim GH
    J Korean Med Sci; 2021 Nov; 36(45):e318. PubMed ID: 34811980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination.
    Naleway AL; Crane B; Irving SA; Bachman D; Vesco KK; Daley MF; Getahun D; Glenn SC; Hambidge SJ; Jackson LA; Klein NP; McCarthy NL; McClure DL; Panagiotakopoulos L; Panozzo CA; Vazquez-Benitez G; Weintraub ES; Zerbo O; Kharbanda EO
    Ther Adv Drug Saf; 2021; 12():20420986211021233. PubMed ID: 34178302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Near real-time vaccine safety surveillance with partially accrued data.
    Greene SK; Kulldorff M; Yin R; Yih WK; Lieu TA; Weintraub ES; Lee GM
    Pharmacoepidemiol Drug Saf; 2011 Jun; 20(6):583-90. PubMed ID: 21538670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.
    Deng L; Glover C; Dymock M; Pillsbury A; Marsh JA; Quinn HE; Leeb A; Cashman P; Snelling TL; Wood N; Macartney K
    Med J Aust; 2022 Aug; 217(4):195-202. PubMed ID: 35781813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COVID-19 Vaccination and Non-COVID-19 Mortality Risk - Seven Integrated Health Care Organizations, United States, December 14, 2020-July 31, 2021.
    Xu S; Huang R; Sy LS; Glenn SC; Ryan DS; Morrissette K; Shay DK; Vazquez-Benitez G; Glanz JM; Klein NP; McClure D; Liles EG; Weintraub ES; Tseng HF; Qian L
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1520-1524. PubMed ID: 34710075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Victorian Specialist Immunisation Services (VicSIS) - bolstering adult clinics for COVID-19 vaccines.
    Gordon SF; Virah Sawmy E; Duckworth E; Wolthuizen M; Clothier HJ; Chea M; Tenneti N; Blow N; Buttery JP; de Luca J; Korman TM; Barnes S; Slade C; Maggs C; Giles ML; Teh BW; Aboltins C; Langan KM; Van Diemen A; Crawford NW
    Hum Vaccin Immunother; 2022 Nov; 18(5):2052701. PubMed ID: 35471988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of COVID-19 mRNA Vaccination Among Young Children in the Vaccine Safety Datalink.
    Goddard K; Donahue JG; Lewis N; Hanson KE; Weintraub ES; Fireman B; Klein NP
    Pediatrics; 2023 Jul; 152(1):. PubMed ID: 37278199
    [No Abstract]   [Full Text] [Related]  

  • 35. The Pioneering Role of the Vaccine Safety Datalink Project (VSD) to Advance Collaborative Research and Distributed Data Networks.
    Fahey KR
    EGEMS (Wash DC); 2015; 3(1):1195. PubMed ID: 26793736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COVID-19 Vaccination Coverage Among Insured Persons Aged ≥16 Years, by Race/Ethnicity and Other Selected Characteristics - Eight Integrated Health Care Organizations, United States, December 14, 2020-May 15, 2021.
    Pingali C; Meghani M; Razzaghi H; Lamias MJ; Weintraub E; Kenigsberg TA; Klein NP; Lewis N; Fireman B; Zerbo O; Bartlett J; Goddard K; Donahue J; Hanson K; Naleway A; Kharbanda EO; Yih WK; Nelson JC; Lewin BJ; Williams JTB; Glanz JM; Singleton JA; Patel SA
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(28):985-990. PubMed ID: 34264911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Better Understanding Adult COVID-19 Vaccination Hesitancy and Refusal: The Influence of Broader Beliefs about Vaccines.
    Boyle J; Nowak G; Kinder R; Iachan R; Dayton J
    Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG), Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Oct; 43(10):1515-1544. PubMed ID: 36456484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Technical guidelines for seasonal influenza vaccination in China (2022-2023)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) on Influenza Vaccination
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Oct; 56(10):1356-1386. PubMed ID: 36274602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Past as Prologue-Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination.
    Dixon MG; Reef SE; Zimmerman LA; Grant GB
    Emerg Infect Dis; 2022 Dec; 28(13):S225-S231. PubMed ID: 36502405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.